Zaviralec nadzornih točk (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zaviralec nadzornih točk" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

68^th place

28^th place

2onkologija.org

low place

2,870^th place

4^th place

8^th place

2^nd place

5^th place

1pharmazeutische-zeitung.de

8,614^th place

low place

1whatisbiotechnology.org

low place

low place

doi.org

Pardoll DM (Marec 2012). »The blockade of immune checkpoints in cancer immunotherapy«. Nature Reviews. Cancer. 12 (4): 252–64. doi:10.1038/nrc3239. PMC 4856023. PMID 22437870.

europa.eu

ema.europa.eu

https://www.ema.europa.eu/en/medicines/human/EPAR/yervoy, vpogled: 5. 11. 2020.
https://www.ema.europa.eu/en/medicines/human/EPAR/opdivo, vpogled: 5. 11. 2020.
https://www.ema.europa.eu/en/medicines/human/EPAR/keytruda, vpogled: 5. 11. 2020.
https://www.ema.europa.eu/en/medicines/human/EPAR/libtayo, vpogled: 5. 11. 2020.
https://www.ema.europa.eu/en/documents/product-information/tecentriq-epar-product-information_sl.pdf, vpogled: 5. 11. 2020.
https://www.ema.europa.eu/en/medicines/human/EPAR/imfinzi, vpogled: 5. 11. 2020.
https://www.ema.europa.eu/en/medicines/human/EPAR/bavencio, vpogled: 5. 11. 2020.

nih.gov

ncbi.nlm.nih.gov

Pardoll DM (Marec 2012). »The blockade of immune checkpoints in cancer immunotherapy«. Nature Reviews. Cancer. 12 (4): 252–64. doi:10.1038/nrc3239. PMC 4856023. PMID 22437870.

pubmed.ncbi.nlm.nih.gov

Pardoll DM (Marec 2012). »The blockade of immune checkpoints in cancer immunotherapy«. Nature Reviews. Cancer. 12 (4): 252–64. doi:10.1038/nrc3239. PMC 4856023. PMID 22437870.

onkologija.org

http://www.onkologija.org/wp-content/uploads/Brosura_Imunoonkologija_2018_zaSplet.pdf Ocvirk J. Imunoonkologija – Nov pristop k zdravljenju raka. Ljubljana 2018.
http://www.onkologija.org/wp-content/uploads/Brosura_Imunoonkologija_2018_zaSplet.pdf Ocvirk J. Imunoonkologija – Nov pristop k zdravljenju raka Ljubljana, 2018.

pharmazeutische-zeitung.de

Annette Mende (4. september 2019). »Der dritte PD-1-Inhibitor«. Pharmazeutische Zeitung (v nemščini).

whatisbiotechnology.org

https://www.whatisbiotechnology.org/index.php/science/summary/checkpoint-inhibitor/immune-checkpoint-inhibitors-are-key-cancer-treatment-tool, vpogled: 5. 11. 2020.